About Capacity Bio
Capacity Bio is a private company based in Palo Alto, California, incorporated in 2021 in Delaware. It has reported $19,210,937 raised in one offering on Form D since January 2023. Its chief executive is Kenneth Horne.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 21, 2022 | Jan 18, 2023 | $19,210,937of $35.3M target | 13 | $1.4M | Equity, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Capacity Bio's Form D filed Jan 18, 2023.
KH
Kenneth Horne
Chief Executive Officer and director
Also a director at Imbria Pharmaceuticals, Pahr Therapeutics and Typewriter Therapeutics.
TI
Taro Inaba
Director
DM
Dylan Morris
Director
AW
Amy Wang
Executive officer and director
CG
Cristina Ghenoiu
Director